BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...

The lack of a healthy exit market is an existential problem for the venture capital industry, writes guest author Dan Gray, ...

One of Australia’s largest industry funds has lifted its venture capital allocation to $100 million, ignoring fears about ...

SAVCA CEO Tshepiso Kobile steps down after a transformative tenure, with Nicola Gubb named interim Executive Director as the ...

As Tshepiso Kobile departs, the Southern African Venture Capital and Private Equity Association has announced Nicola Gubb ...

The broader conditions that shaped 2023, including tight capital, cautious investors, and high borrowing costs, never went ...

Key insights from Jeff Crowe​​​​​​​ - On what differentiates an outstanding venture capital investor: “They have a nose for ...

Billionaire Nik Storonsky’s artificial intelligence-focused venture capital firm has completed a funding round of $250 ...

Cara Whitehill, Vice President at Thayer Investment Partners, brings a bold investor lens to the Skift Data + AI Summit stage.

Anca Manitiu, Deputy CEO of Impetum Group - one of the biggest private equity managers in Romania - analyzes the recent ...

“Private equity is very troubled, I believe, especially in the large buyouts, venture capital and the rise of continuation ...

Among the key asks of AIFs has been that banks and NBFCs should not be asked to provision for AIF investments in ...